Gentamicin-induced acute renal failure is characterized by a decrease in re
nal plasma flow and creatinine clearance. Endothelins (ET) are potent renal
vasoconstrictors. The aim of this work is to assess the role of ET-1 in ge
ntamicin-induced renal failure. Renal glomerular release of ET-1 was measur
ed in rats with gentamicin-induced nephrotoxicity (100 mg/kg/ day, s.c. for
2, 4 or 6 days). Glomeruli were isolated and incubated for 24 h in RPMI-16
40. Glomerular supernatant and plasma concentration of ET-1 were measured b
y RIA. Renal failure was assessed by insulin, para-aminohippuric and creati
nine clearance and histological studies. Gentamicin induced a dose number-d
ependent increase in plasma creatinine and a decrease in creatinine clearan
ce. This was accompanied by a marked decrease in inulin and para-aminohippu
ric acid clearance, as well as by a marked tubular necrosis, without altera
tions in glomerular structures. Plasma ET-1 concentration and glomerular ET
-1 release were also increased in gentamicin-treated rats. When 10(-5) M ge
ntamicin was added to control glomeruli, ET-1 production was not modified (
36.4 +/- 2.2 vs. 35.2 +/- 1.7 pg/ml/24 h). All these results suggest that e
levated ET-1 plasma levels and increased glomerular release of ET-1 could m
ediate, at least in part, the decrease in glomerular filtration rate observ
ed in gentamicin-induced ARF.